Deposit $100 to get a $100 trading bonus. Use the promo code AMANAWEB.
Deposit $200 to get a $100 trading bonus.
Use the promo code AMANAWEB.

+11.97%
Today
+11.97%
1D
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 12:00 PM
Sat
Closed
Name
Codexis Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
Market Cap
158.12M
Avg Daily Volume
1.06M
52 Week High
3.87 USD
52 Week Low
0.96 USD
Trading Hours
See hours
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Codexis
+11.97%
Codexis, Inc. Stock 12‑Month Price Target Cut to $6.5, Implies 339% Upside
tradingview.com
11h ago

Codexis
+11.97%
Codexis Q2 Earnings Call Highlights
finance.yahoo.com
20h ago

Codexis
+11.97%
CDXS: Q2 2026 saw revenue of $14.9M, improved margins, new financing, and strong ECO Synthesis progress
tradingview.com
20h ago

Show more
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.